|
HS Code |
322737 |
| Chemical Name | Tetracaine Hydrochloride |
| Cas Number | 136-47-0 |
| Molecular Formula | C15H25ClN2O2 |
| Molecular Weight | 300.83 g/mol |
| Appearance | White crystalline powder |
| Solubility | Soluble in water and alcohol |
| Melting Point | 149-153°C |
| Ph Of Solution | 4.5-6.5 (1% solution) |
| Storage Conditions | Store at room temperature, protected from light |
| Primary Use | Local anesthetic |
| Synonyms | Amethocaine hydrochloride |
| Stability | Stable under normal temperatures and pressures |
| Odor | Odorless |
As an accredited Tetracaine Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Tetracaine Hydrochloride is packaged in a sealed, amber glass vial containing 25 grams, labeled with hazard warnings and storage instructions. |
| Shipping | Tetracaine Hydrochloride is shipped in tightly sealed, chemical-resistant containers to prevent contamination and moisture exposure. Packages are clearly labeled with hazard information, handled by trained personnel, and transported following regulations for controlled substances and hazardous chemicals. Temperature and light protection may be provided to maintain product stability during transit. |
| Storage | Tetracaine Hydrochloride should be stored in a tightly closed container, protected from light and moisture. Keep it at controlled room temperature, ideally between 15°C and 30°C (59°F–86°F). Store in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers. Always follow regulatory guidelines and label containers clearly to ensure safe handling. |
|
Purity 99%: Tetracaine Hydrochloride with 99% purity is used in ophthalmic procedures, where it ensures rapid and effective local anesthesia. Particle size <10 microns: Tetracaine Hydrochloride with particle size under 10 microns is used in topical formulations, where it enhances absorption and onset of action. Melting point 149°C: Tetracaine Hydrochloride with a melting point of 149°C is used in sterile injectable solutions, where it guarantees product stability during autoclaving. Stability temperature up to 40°C: Tetracaine Hydrochloride stable up to 40°C is used in field medical kits, where it maintains anesthetic efficacy in varying environmental conditions. pH range 4.5-6.0: Tetracaine Hydrochloride formulated for a pH range of 4.5-6.0 is used in mucosal applications, where it minimizes tissue irritation and optimizes patient safety. Viscosity grade low: Tetracaine Hydrochloride with low viscosity grade is used in nasal sprays, where it allows for uniform mucosal coverage and improved patient compliance. Moisture content <0.5%: Tetracaine Hydrochloride with moisture content below 0.5% is used in sterile powder preparations, where it reduces hydrolysis risk and extends shelf life. Molecular weight 300.82 g/mol: Tetracaine Hydrochloride at 300.82 g/mol is used in pharmacological research, where it provides consistent dosing and reproducible results. |
Competitive Tetracaine Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In this facility, we watch batch after batch of Tetracaine Hydrochloride leave our reactors as bright, consistent crystals. Our staff’s careful attention to process controls means this local anesthetic meets rigid pharmaceutical standards time after time. Across the industry, Tetracaine Hydrochloride stands out for its impressive potency and longevity compared to other commonly used anesthetics. Every shipment we produce needs to achieve a reliable melting point and a narrow purity profile, often over 99%. That’s not marketing talk; it’s the difference between dependable results and batches that miss their mark.
Several years ago, we began refining our process, using high-purity starting materials sourced directly from audited partners. Impurities can change the reactivity rate and stability of the hydrochloride salt, and even a small deviation in reagent quality shows up as a deviation in the finished compound’s effectiveness. By investing in meticulous purification and drying steps, we manage to keep free acid levels and related substances well below global pharmacopeia limits. Chemists in the lab routinely perform GC and HPLC tests on random samples, making sure degradation products stay low enough to meet even the strictest regulatory expectations.
Tetracaine Hydrochloride differs noticeably from other local anesthetics like lidocaine or procaine. The molecular backbone—derived from p-aminobenzoic acid but with a unique butyl group substitution—means a higher lipid solubility. In real terms, that translates to a much slower onset of metabolism after injection. Surgeons and clinicians choosing our Tetracaine Hydrochloride expect a longer-lasting anesthetic effect, helping manage pain through more involved procedures without constant re-dosing. Sometimes that’s the difference between a smooth operation and one punctuated by avoidable discomfort. We know the drug’s half-life can reach nearly three hours in spinal anesthesia. That added duration reduces interruptions in the operating room, making every minute count for patient safety and surgical efficiency.
The unique challenges of Tetracaine Hydrochloride manufacturing lie in its moisture sensitivity and the formation of stable, free-flowing crystalline powder. Early in our production journey, we encountered multiple setbacks related to hygroscopicity. Residual water vapor, if left unchecked even for a few minutes, can catalyze degradation into less active byproducts. To address this, we invested in upgrade-grade desiccation equipment and instituted an airtight transfer protocol at every scale-up step. Every production line worker understands how humidity can ruin a batch that’s otherwise perfectly synthesized.
Process reliability comes from more than just equipment. It’s the muscle memory of seasoned operators who recognize the red flags in vacuum filtration or during the critical precipitation stage. If crystals start forming too quickly, the risk of occluded solvent increases, causing downstream problems in drying and packaging. That’s why teams log not just yields but observations of crystal habit, particle size, and color. The goal is clear: every lot shipped represents the finest, most predictable anesthetic we can produce—and no step occurs without direct human oversight.
The complexity of our process doesn’t stop at synthesis. As regulators step up scrutiny, we find ourselves running more stability trials than ever before. We store reference samples at various temperatures to simulate real-world transport and storage. Several years ago, a client in Southeast Asia highlighted the challenges of warehouse heat on long-term shelf life. Working with their feedback, we adjusted our packaging and added moisture-barrier liners, and have seen a dramatic drop in field complaints and retest failures since.
Manufacturing Tetracaine Hydrochloride isn’t only about chemistry—it’s deeply intertwined with public health outcomes. Global demand requires us to certify lots to various monographs, and those standards don’t always align. Some ask for more stringent endpoints on loss-on-drying or chloride ion content. We keep reference guides updated in multiple languages and frequently update our procedures to harmonize differences between Asia, Europe, and North America’s regulatory requirements. Each region asks for something a bit different in terms of particle profile or packaging label. That means our QA staff maintain a rotation, constantly on alert for changes in pharmacopeia updates or feedback from downstream formulation chemists.
For those of us on the manufacturing floor, there’s a clear understanding that an error measured at milligrams per kilo could mean a failed batch worth hundreds of thousands of dollars. During scale-up runs, our approach relies on real-time monitoring rather than back-end audits. Technicians routinely check the clarity of filtrates, watch for any color shift in solutions, and reject anything that shows signs of oxidation. Mistakes in quality review don’t just lead to paperwork headaches; they translate directly into patient safety risks.
The difference in standards between Tetracaine Hydrochloride and other similar anesthetics really matters in practice. Chloride salt forms, for example, significantly improve the product’s water solubility—vital for injectable formulations. We engineer our process to avoid over-acidification, which would pull down the pH and threaten stability in finished ampoules. On the rare occasion we find a batch with elevated moisture or subpar assay, the whole lot gets recycled. Technicians take pride in the fraction of lots accepted the first time—not because the spec sheet demands it, but because real people’s experiences depend on every dose acting exactly as it should.
Hospital pharmacies, compounding labs, and contract developers expect our Tetracaine Hydrochloride to perform on time, every time. One feedback we often hear from anesthetists: longer block duration reduces their need for top-up injections. Our product’s molecular structure makes this possible, delivering a pronounced local block that matures over minutes and then lasts comfortably into the procedure. It’s not an academic difference, it influences everyday outcomes for conscious patients undergoing minor surgery, ophthalmic procedures, or spinal blocks.
Unlike some anesthetic options that rely on rapid but short action—such as lidocaine—Tetracaine Hydrochloride gives clinicians room to manage diverse cases with fewer interruptions. We’ve received letters describing the sense of control this grants to teams in busy environments. Colleagues remark on the sharpness and clarity of our finished powder, both a testament to our purification steps and a marker of batch-to-batch sameness. Feedback loops between manufacturing and clinical use guide our gradual process refinements; every specification tweak comes from engagement with the people who put our compound to use.
For compounding pharmacies, solubility isn’t just an afterthought. They need crystals that fully dissolve within expected timeframes under approved diluent conditions. We refined our grinding process to achieve an average particle size under 50 microns, ensuring no “floaters” or aggregates escape filtration. Pharmacists rely on this consistency to keep preparations sterile and free of clumps—a safety factor when drawing up solutions intended for direct injection.
Ophthalmic surgeons request our Tetracaine Hydrochloride for procedures like cataract removal and corneal repair because of its rapid mucosal penetration. Its high-potency block allows for clear surgical fields without lasting cloudiness or extended recovery. The difference becomes especially clear in comparison to agents like proparacaine, which dissipate sooner and require frequent redosing.
Dentists and oral surgeons cite the product’s smooth injection profile and low tissue reactivity in soft palate nerve blocks. Detailed feedback from dental partners prompted us to investigate trace metal contamination, leading to investments in resin-based purification columns that further reduced the risk of injection-site reactions. Because Tetracaine’s molecular profile sits close to threshold allergy risks, our focus on impurity isolation remains a key part of our batch release strategy.
Spinal anesthesia demarcates a separate line of client expectations. For procedures demanding a profound block lasting up to several hours, Tetracaine Hydrochloride outperforms many traditional local anesthetics. Every ampoule or vial filled at our site undergoes light transmission and pH testing, confirming clarity and minimal particulate risk. A recent partnership with a university hospital provided us with direct procedure data, confirming that our product contributed to notable reductions in patient discomfort scores during longer operations.
Working with such a potent molecule carries responsibility. Every gram released into the market ties our reputation to patient outcomes far outside our factory gates. We track shipped lots using serialized identifiers and maintain a thorough log of every test, calibration, and environmental monitoring record tied to those batches. On rare occasions where a client reports an issue—anything from complaints about caking to sharper-than-expected odor changes—we conduct full investigations. This drives our safety culture and continuous improvement mind-set.
We treat shelf life claims as more than simply numbers on a label. Stability isn’t just about resisting heat; it covers resistance to light, dryness, and oxygen ingress. Based on feedback, we upgraded to dark-glass packaging and triple-laminated interior pouching for bulk clients with slow inventory turnover. Trace moisture stays low even through shipment across humid regions, thanks to integrated desiccant canisters inside each master carton. Pharmacy customers tell us our lots outlast competitors during regional summers.
Documentation and traceability strengthen confidence as much as technical quality. Our onsite quality team maintains a reference archive for all outgoing lots—a practice we adopted after a regulatory review in Central Europe highlighted the need for decade-long trace retention. That means if a query arises years down the line, we’re not scrambling to reconstruct records; the test sheets, chromatograms, and process notes all stand ready for audit. Every associate on our team understands that these records aren’t formalities—they’re the backbone of client trust and regulatory compliance.
Tetracaine Hydrochloride production means navigating regularly shifting regulatory expectations across markets. With each change—whether a lower allowable impurity limit or a new analytical reference—we reevaluate not just our own practices but our input materials and suppliers. We’ve shifted sourcing more than once, sometimes at significant cost, to keep ahead of changing safety standards. On a few occasions, newly introduced limits required overnight tweaks to our purification wash protocol, and our laboratory team responded with 24-hour testing shifts to avoid shipment delays.
No regulator expects miracles, but they do demand transparency and reliable remedial action. Our documentation includes ongoing stability studies, impurity trend analyses, and corrective measures for any out-of-spec result. When we identify irregularities, a review team traces every possible contributing cause, not just correcting product output but adjusting process conditions to limit recurrence risk. This cycle builds a sense of pride among our operators, who see their adjustments reflected in client satisfaction metrics and regulatory inspection scores.
We also recognize the trend toward environmental scrutiny. Handling process waste, water runoff, and spent solvents isn’t just a cost of doing business—it’s part of our social license to operate. Our waste neutralization and recycling systems comply with the environmental rules of each territory in which we export. From developing molecular sieves for solvent recovery to working with licensed disposal centers, every step happens with the expectation that the final compound must be as safe for the environment as it is for patients in the operating room.
In a crowded field of local anesthetics, the selection of Tetracaine Hydrochloride signals a deliberate choice by formulation specialists. Its chemical signature—a long, lipophilic alkyl chain—delivers superior anesthetic penetration and duration of effect when compared to more basic analogs. Lidocaine dominates quick interventions because of its rapid onset and short tail, but for situations needing extended numbness, the edge goes to Tetracaine’s chloride salt. The product’s slower hydrolysis in human plasma makes it the agent of choice for surgeries anticipated to last beyond an hour, whether spinal or mucosal.
Another common question concerns potential toxicity. All local anesthetics carry dose-dependent risk, but Tetracaine Hydrochloride warrants particular care at high concentration. Our manufacturing process and testing protocols aim to produce consistent batches capable of safe dilution for tailored use, supporting practitioners no matter the intended application. Clinical partners report that clear dosing and concentration ranges—made possible by measurable batch purity and validated solvent compatibility—help limit complications without sacrificing anesthetic strength. Precise control in your starting material shapes every experience downstream.
Manufacturing Tetracaine Hydrochloride never reaches a point of “set and forget.” Our research and development teams routinely examine replacement reagents or process improvements to drive yield and lower environmental impact. Recent investments into higher-efficiency reactors brought down energy requirements and allowed us to recover more solvent for reuse. Process engineers speak proudly about these steps, not just for the operational gain but for the reassurance it brings to clients conscious of sustainability.
End-user feedback continues to shape each procedural tweak. One year, an uptick in dermal application demand drove us to revalidate the product’s skin permeation characteristics in compounded creams. Collaboration with pharmaceutical partners enables us to experiment with new excipients, ensuring the product stays at the leading edge of formulation compatibility. None of these changes would matter if we lost sight of the baseline requirement: a crystalline product that’s chemically pure, physically consistent, and trusted for its intended use.
Much of our institutional knowledge comes from lessons learned in scaling batches upward, or navigating unexpected supply shocks. Whether wrestling with feedstock shortages or pivoting process equipment in a hurry, we’ve built a resilient workflow that aims to insulate our partners from unpredictability. Our willingness to share technical insights and batch performance data supports customers in their own compliance efforts and fosters mutual growth across the value chain.
What gives us satisfaction isn’t just moving another drum off the loading dock. It’s fielding that late-night call from a pharmacist confirming everything dissolved as expected. It’s seeing a surgeon’s letter arrive, noting smooth patient recovery after a spinal procedure. As a manufacturer, we occupy an early but essential link in the chain leading to restored comfort, successful operations, and safe clinical practice.
Tetracaine Hydrochloride’s unique properties—its duration of action, manageable reactivity, and clinical versatility—trace directly to each deliberate step we take in its production. Our commitment stands rooted in that hands-on experience: every operator’s careful monitoring, every chemist’s data review, and every improvement born from real-world use. Trust earned over years, not just from specifications met but from challenges faced and partnerships strengthened, sets our product apart. Our continuing focus is to never let that trust diminish.